Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
0.285
-0.022 (-7.17%)
At close: Mar 6, 2026, 4:00 PM EST
0.285
+0.000 (0.07%)
After-hours: Mar 6, 2026, 7:47 PM EST
Ernexa Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 8 | 15 | 10 | 17 | 217 | - | |
| Market Cap Growth | -55.66% | 55.53% | -41.17% | -92.39% | - | - | |
| Enterprise Value | 5 | 49 | 45 | 6 | 196 | - | |
| Last Close Price | 0.28 | 4.41 | 26.92 | 48.30 | 1251.00 | - | |
| PS Ratio | 7719.26 | 25.95 | 142.82 | - | - | - | |
| PB Ratio | 0.63 | 8.88 | 4.35 | 1.36 | 8.51 | - | |
| P/TBV Ratio | 5.06 | - | 51.66 | 1.64 | 9.25 | - | |
| EV/Sales Ratio | 5224.26 | 83.40 | 658.24 | - | - | - | |
| Debt / Equity Ratio | 0.16 | 0.40 | 18.74 | 0.10 | 0.11 | 0.38 | |
| Net Debt / Equity Ratio | -0.70 | -0.61 | 15.35 | -0.85 | -0.56 | 0.17 | |
| Net Debt / EBITDA Ratio | 0.25 | 0.06 | -1.66 | 0.38 | 0.52 | -0.18 | |
| Net Debt / FCF Ratio | 0.26 | 0.06 | -1.68 | 0.48 | 0.60 | -0.16 | |
| Asset Turnover | 0 | 0.02 | 0.00 | - | - | - | |
| Quick Ratio | 1.49 | 0.74 | 1.22 | 1.62 | 4.81 | 0.52 | |
| Current Ratio | 1.58 | 0.80 | 1.46 | 1.79 | 5.10 | 0.55 | |
| Return on Equity (ROE) | - | -2264.31% | -302.20% | -130.70% | -739.07% | -83.79% | |
| Return on Assets (ROA) | -89.29% | -39.64% | -36.19% | -63.25% | -77.17% | -32.34% | |
| Return on Capital Employed (ROCE) | -246.30% | -740.00% | -48.60% | -186.20% | -98.50% | -74.10% | |
| Earnings Yield | -237.81% | -294.88% | -223.12% | -148.88% | -56.47% | - | |
| FCF Yield | -122.24% | -107.29% | -210.34% | -128.86% | -10.89% | - | |
| Buyback Yield / Dilution | -1252.42% | -156.81% | -74.17% | -40.92% | -146.19% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.